Calls for country of origin to be mandatory on pharmaceutical labelling

With the Covid pandemic shining the spotlight on gaps in Australia’s pharmaceutical supply chain, a logistics and economics think-tank is calling on the government to compel drug manufacturers to disclose the country of  origin of all active pharmaceutical ingredients (API) in their products. Logistics expert, John Blackburn, Chair of the Institute of Integrated Economics Research 

Continue Reading…